Details of the Drug

General Information of Drug (ID: DMZ7QN8)

• Drug Name: NV-196
• Synonyms: Triphendiol; NV-196; SCHEMBL2604720; UNII-6I62LZU21D component KQCJZAUNKSGEFM-UNMCSNQZSA-N

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C22H20O4
  Canonical SMILES: COC1=CC=C(C=C1)C2C(COC3=C2C=CC(=C3)O)C4=CC=C(C=C4)O
  InChI: 1S/C22H20O4/c1-25-18-9-4-15(5-10-18)22-19-11-8-17(24)12-21(19)26-13-20(22)14-2-6-16(23)7-3-14/h2-12,20,22-24H,13H2,1H3/t20-,22-/m0/s1
  InChIKey: KQCJZAUNKSGEFM-UNMCSNQZSA-N
• Cross-matching ID:
  PubChem CID: 25022868
  CAS Number: 1213777-80-0
  UNII: 6I62LZU21D
  DrugBank ID: DB06588
  TTD ID: D0I5BN

References

• [1] Phase 1a safety and pharmacokinetic study of oral NV-196 in patients with solid tumours. J Clin Oncol (Meeting Abstracts) May 2008 vol. 26 no. 15_suppl 14615.